KLBF — Income Statement (Laba Rugi)
Laporan Keuangan Ringkasan laba rugi, neraca, dan arus kas — KLBF Kalbe Farma Tbk
| Dalam Jutaan IDR | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total Pendapatan | 9,678,361 | 35,324,544 | 25,988,297 | 17,079,294 | 8,845,368 | 32,627,776 | 24,238,763 | 16,328,252 | 8,363,029 |
| Total Beban Pokok Penjualan | (5,971,476) | (21,269,024) | (15,431,048) | (10,053,641) | (5,169,098) | (19,670,736) | (14,721,788) | (9,863,754) | (5,041,736) |
| Laba Kotor | 3,706,885 | 14,055,520 | 10,557,248 | 7,025,653 | 3,676,270 | 12,957,040 | 9,516,975 | 6,464,498 | 3,321,292 |
| Total Beban Usaha | (2,394,487) | (9,417,242) | (7,250,563) | (4,579,554) | (2,295,092) | (8,787,449) | (6,514,690) | (4,171,313) | (2,101,351) |
| Laba Usaha | 1,312,398 | 4,638,278 | 3,306,685 | 2,446,099 | 1,381,178 | 4,169,591 | 3,002,285 | 2,293,185 | 1,219,941 |
| Penghasilan/Beban Lain-Lain | 39,478 | 140,197 | 170,441 | 166,693 | 48,086 | 49,283 | 89,755 | 74,247 | 47,633 |
| Laba Sebelum Pajak | 1,351,876 | 4,778,475 | 3,477,127 | 2,612,791 | 1,429,264 | 4,218,874 | 3,092,040 | 2,367,432 | 1,267,574 |
| Beban Pajak Penghasilan | (299,197) | (1,034,100) | (782,359) | (584,701) | (318,806) | (972,305) | (695,706) | (536,619) | (279,996) |
| Laba Bersih Dari Operasi Yang Dilanjutkan | 1,052,679 | 3,744,375 | 2,694,768 | 2,028,091 | 1,110,458 | 3,246,570 | 2,396,334 | 1,830,812 | 987,578 |
| Hak Minoritas | - | - | - | - | - | - | - | - | - |
| Penyesuaian Proforma | - | - | - | - | - | - | - | - | - |
| Laba Bersih Tahun Berjalan | 1,052,679 | 3,744,375 | 2,694,768 | 2,028,091 | 1,110,458 | 3,246,570 | 2,396,334 | 1,830,812 | 987,578 |
| Pendapatan Komprehensif Lain | (2,500) | (14,499) | (11,278) | (39,447) | 27,876 | 21,916 | (15,348) | 32,983 | 5,244 |
| Jumlah Laba Komprehensif | 1,050,179 | 3,729,876 | 2,683,490 | 1,988,644 | 1,138,334 | 3,268,486 | 2,380,986 | 1,863,795 | 992,821 |
| Laba Bersih Yang Dapat Diatribusikan | 1,052,679 | 3,744,375 | 2,694,768 | 2,028,091 | 1,110,458 | 3,246,570 | 2,396,334 | 1,830,812 | 987,578 |
| Laba Komprehensif Yang Dapat Diatribusikan | 1,050,179 | 3,729,876 | 2,683,490 | 1,988,644 | 1,138,334 | 3,268,486 | 2,380,986 | 1,863,795 | 992,821 |
Key Ratios — KLBF
| Rasio | Q1 2026 ×4 | Q4 2025 | Q3 2025 ×1⅓ | Q2 2025 ×2 | Q1 2025 ×4 | Q4 2024 | Q3 2024 ×1⅓ | Q2 2024 ×2 | Q1 2024 ×4 |
|---|---|---|---|---|---|---|---|---|---|
| Profitabilitas | |||||||||
| Gross Margin (%) | 38.30% | 39.79% | 40.62% | 41.14% | 41.56% | 39.71% | 39.26% | 39.59% | 39.71% |
| Operating Margin (%) | 13.56% | 13.13% | 12.72% | 14.32% | 15.61% | 12.78% | 12.39% | 14.04% | 14.59% |
| Net Margin (%) | 10.63% | 10.38% | 10.13% | 11.56% | 12.17% | 9.93% | 9.81% | 11.06% | 11.45% |
| ROE (%) | 16.94% | 15.72% | 15.27% | 17.64% | 18.31% | 14.22% | 14.30% | 16.56% | 17.11% |
| ROA (%) | 12.87% | 11.94% | 11.66% | 13.39% | 14.09% | 11.01% | 11.03% | 12.64% | 13.23% |
| Per Lembar Saham | |||||||||
| EPS (Rp) | 87,92 | 78,29 | 74,95 | 84,37 | 92,01 | 69,22 | 67,74 | 77,12 | 81,82 |
| BVPS (Rp) | 519,02 | 497,99 | 490,80 | 478,42 | 502,35 | 486,80 | 473,87 | 465,76 | 478,10 |
| Valuasi | |||||||||
| PER (x) | 8.19x | 9.20x | 9.61x | 8.53x | 7.83x | 10.40x | 10.63x | 9.34x | 8.80x |
| PBV (x) | 1.39x | 1.45x | 1.47x | 1.50x | 1.43x | 1.48x | 1.52x | 1.55x | 1.51x |
| Struktur Modal | |||||||||
| DER (x) | 0.24x | 0.24x | 0.21x | 0.22x | 0.21x | 0.20x | 0.20x | 0.21x | 0.20x |